• LNP Storage of Self-Replicating RNA Vaccines

  2026-08-23

  The reference study systematically examines how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its central practical finding is that RNAse-free PBS containing 10% sucrose supported stability and in vivo potency during storage at −20 °C, while lyophilization also preserved measurable bioactivity.

• ER-Targeted EISA Peptides and Cancer Cell Fate

  2026-08-22

  The reference study develops a phosphotyrosine-containing peptide that undergoes alkaline phosphatase-instructed self-assembly and uses p-toluenesulfonamide to direct the resulting assemblies to the endoplasmic reticulum. In cancer cells with elevated alkaline phosphatase, this design promotes ER stress, apoptosis, and necroptosis while improving potency relative to non-targeted intracellular self-assembly.

• Nicotinamide Riboside Chloride in RGC Assays

  2026-08-22

  Nicotinamide Riboside Chloride (NIAGEN) can add a controllable NAD+ variable to retinal ganglion cell research. This article presents an assay-centered framework for separating RGC lineage specification from metabolic resilience, improving interpretation in neurodegenerative disease models.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Assay Logic

  2026-08-21

  The FITC Goat Anti-Mouse IgG (H+L) Antibody is more than a fluorescent label: it is a critical variable in reproducible mouse IgG detection. This guide connects secondary-antibody design with the orthogonal assay strategy used to study Amt-1 antiviral activity, while distinguishing product specifications from practical workflow decisions.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-20

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for HRP immunoblots captured on X-ray film or CCD cameras. It supports sensitive protein detection by chemiluminescence, but is intended for HRP workflows rather than fluorescent or radioisotopic assays.

• TCEP Hydrochloride for Protein Workflows

  2026-08-20

  TCEP hydrochloride provides odorless, water-soluble disulfide reduction for protein digestion, structural analysis, and redox assays. This article translates its chemistry into practical workflows and shows how controlled reduction can support, but not replace, ubiquitin-directed DNA-protein crosslink research.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-19

  Build a sensitive, reproducible immunoblot workflow for scarce targets, from membrane preparation through exposure optimization. This guide connects the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) with a colorectal cancer study to show how stronger signal control can support pathway validation without confusing detection sensitivity with biological proof.

• ER Stress and Intestinal Stem Cell Dysfunction

  2026-08-19

  The reference study identifies tunicamycin-induced endoplasmic reticulum stress as a damaging influence on intestinal stem-cell abundance, differentiation, proliferation, and survival. Its mechanistic contribution is the association of these effects with GRP78/ATF6/CHOP activation and suppression of p44/42 MAPK signaling, providing a framework for interpreting RNA-expression measurements in intestinal injury models.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-18

  Learn how to use the hypersensitive ECL Chemiluminescent Substrate Detection Kit for low-abundance targets on nitrocellulose or PVDF membranes. The workflow combines HRP-based sensitivity, extended signal capture, and practical troubleshooting for reproducible western blot chemiluminescent detection.

• Canagliflozin for Renal Mitochondrial Research

  2026-08-18

  Canagliflozin enables researchers to connect renal glucose reabsorption inhibition with proximal-tubule mitochondrial structure and bioenergetics. This workflow-focused guide shows how to design cell and mouse studies, separate glucose-dependent effects from direct cellular readouts, and troubleshoot solvent, sex, and respirometry variables.

• Mechanical Stress, Cytoskeleton, and Autophagy

  2026-08-17

  The reference study shows that compression-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules provide an auxiliary contribution. Its experimental design combines controlled compression, cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting to distinguish structural requirements in mechanotransduction.

• CTOP: A Causal Tool for μ-Opioid Studies

  2026-08-17

  CTOP is a selective μ-opioid receptor antagonist for separating receptor-level effects from circuit-level pain phenotypes. This guide translates recent mouse findings on mechanical opioid hypersensitivity into practical assay design, controls, and interpretation.

• Scalable EPSC-Derived MSC EV Manufacturing

  2026-08-16

  Gong and colleagues developed a bioreactor-based platform that converts extended pluripotent stem cells into expandable induced mesenchymal stromal cells and therapeutically active extracellular vesicles. The study addresses donor variability and limited manufacturing scale while providing preclinical evidence of comparable activity to primary MSC-derived vesicles in bleomycin-induced pulmonary fibrosis.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease

  2026-08-15

  Lee and colleagues used anthraquinone-based structural optimization to identify compound 8c, a potent allosteric PDK4 inhibitor with activity in biochemical, metabolic, allergic, and cancer-related models. The study supports the lipoamide-binding site as a tractable design region while also showing why pharmacokinetic, mechanistic, and disease-model data must be interpreted together.

• PXDN, LDHA, and Glycolysis in Glioblastoma

  2026-08-14

  The reference study integrates transcriptomic network analysis with cellular and in vivo experiments to identify peroxidasin (PXDN) as a glycolysis-associated driver of glioblastoma progression. Its knockdown and LDHA-rescue results support a PXDN–LDHA axis that links metabolic reprogramming with malignant behavior, while also defining important directions for validation in patient-derived models.

581 records 9/39 page Previous Next First page 上5页 678910 下5页 Last page